Medical College of Wisconsin
CTSIResearch InformaticsREDCap

GDAP1 orchestrates redox signaling at membrane contact sites to preserve axonal integrity in Charcot-Marie-Tooth disease. Neurobiol Dis 2026 Sep;227:107512

Date

06/29/2026

Pubmed ID

42365934

DOI

10.1016/j.nbd.2026.107512

Scopus ID

2-s2.0-105043128669 (requires institutional sign-in at Scopus site)   1 Citation

Abstract

Pathogenic variants in GDAP1 cause Charcot-Marie-Tooth disease (CMT), an inherited peripheral neuropathy characterized by progressive axonal degeneration. Although GDAP1 is an atypical glutathione S-transferase localized to the outer mitochondrial membrane, it has been proposed to function as a redox sensor that likely maintains inter-organelle communication in neurons. However, the mechanisms by which GDAP1 performs these functions remain unclear. To address this question, we here used a robust multi-tier approach that combines high-resolution and live-cell imaging with pH-sensitive probes, membrane contact sites (MCSs) analysis, lipid studies, transcriptomics, and nerve ultrastructural studies in both patient-derived fibroblasts and Gdap1-/- mice. We find that deletion of the GDAP1 gene induces localized pH and redox imbalances at mitochondria-lysosomes contact sites, which propagate to defective mitochondria-peroxisome interactions, impaired peroxisome biogenesis and morphology, leading to altered lipid homeostasis. These defects are accompanied by axonal organelle mislocalization, disruption of nodes of Ranvier, and structural abnormalities in peripheral nerves. Investigations on the potential reversibility of these processes, reveal that restoration of redox balance rescues MCS organization, identifying a therapeutically tractable MCS-peroxisome axis downstream of GDAP1. Together, our findings position GDAP1 as a redox-sensing organizer of mitochondrial membrane contact sites whose dysfunction triggers a cascade of organelle and axonal defects underlying CMT pathogenesis. Thus, this new knowledge should be taken into consideration in the future design of therapeutic interventions that can ameliorate the symptoms of this dismal disease.

Author List

Cantarero L, Roldán M, Rodríguez-Sanz M, Mathison AJ, Olivares-Fuentes M, Díaz-Osorio Y, Pijuan J, Frías M, Urrutia R, Hoenicka J, Palau F

Author

Angela Mathison PhD Associate Professor in the Surgery department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Animals
Axons
Charcot-Marie-Tooth Disease
Fibroblasts
Humans
Lysosomes
Mice
Mice, Knockout
Mitochondria
Nerve Tissue Proteins
Oxidation-Reduction
Peroxisomes
Signal Transduction